GlassScriptPhysician profile
James Edward Gilbert
NPI 1164472569
$1,652.00
in general payments reported to CMS, 2019-2025
13 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2021: $360 · 2022: $237 · 2023: $195 · 2024: $443 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $426 · Travel and Lodging: $379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.40 |
| Travel and Lodging | $378.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $523.95 | 2021-2025 | Cobra, Stryker, Alphavent |
| Supreme Orthopedic Systems, LLC | $378.57 | 2024 | |
| Smith+Nephew, INC. | $342.33 | 2019-2021 | |
| Djo, LLC | $71.68 | 2023 | Aircast, Donjoy, Procare |
| Depuy Synthes Sales INC. | $57.97 | 2019-2025 | Monovisc |
| Vericel Corporation | $56.36 | 2021-2022 | |
| Centinel Spine, LLC | $49.18 | 2025 | Prodisc C Vivo |
| Fidia Pharma USA INC. | $44.13 | 2022-2024 | Hymovis |
| Trice Medical, INC. | $39.53 | 2019 | |
| Amgen INC. | $26.02 | 2025 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $21.84 | 2024 | A.L.P.S. |
| Pacira Pharmaceuticals Incorporated | $21.73 | 2024 | Exparel |
| Ermi LLC | $18.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.